XBiotech (XBIT) Construction in Progress (2014 - 2016)
XBiotech (XBIT) posted quarterly Construction in Progress of $20.0 million for Q4 2016, up 92.63% year-over-year from $10.4 million in Q1 2016, and up 3.14% quarter-over-quarter from $19.4 million in Q3 2016.
XBiotech (XBIT) Construction in Progress (2014 - 2016) Analysis & Trends
XBiotech's Construction in Progress history runs 3 years deep, the most recent figure standing at $20.0 million for Q4 2016.
- In Q4 2016, Construction in Progress rose 92.63% year-over-year to $20.0 million; the TTM figure through Dec 2016 stood at $20.0 million (up 92.63% YoY), while the FY2016 annual figure was $20.0 million, up 92.63% from the prior year.
- Construction in Progress for Q4 2016 stood at $20.0 million, up from $19.4 million in the prior quarter.
- The five-year high for Construction in Progress was $20.0 million in Q4 2016, with the low at $886000.0 in Q4 2014.
- The 3-year median for Construction in Progress is $12.0 million (2015), against an average of $11.3 million.
- The sharpest annual moves came in 2015 and 2016: Construction in Progress soared 1070.54% in 2015, then surged 92.63% in 2016.
- XBiotech's Construction in Progress stood at $886000.0 in 2014, then jumped by 1070.54% to $10.4 million in 2015, then soared by 92.63% to $20.0 million in 2016.
- Business Quant data shows XBIT's Construction in Progress at $20.0 million in Q4 2016, $19.4 million in Q3 2016, and $17.1 million in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 152.67 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | XBiotech | 68.90 Mn | 68.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 19.98 Mn |
| Sep 30, 2016 | 19.37 Mn |
| Jun 30, 2016 | 17.09 Mn |
| Mar 31, 2016 | 13.71 Mn |
| Dec 31, 2015 | 10.37 Mn |
| Sep 30, 2015 | 6.61 Mn |
| Jun 30, 2015 | 2.68 Mn |
| Dec 31, 2014 | 886,000.00 |